ALBERT DAVID
Back to Balance Sheet
|
ALBERT DAVID Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹4.62 Cr | ₹4.52 Cr | ₹1.96 Cr | ₹1.63 Cr | ₹4.03 Cr |
What is the latest Contingent Liabilities ratio of ALBERT DAVID ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹4.62 Cr |
| Mar2024 | ₹4.52 Cr |
| Mar2023 | ₹1.96 Cr |
| Mar2022 | ₹1.63 Cr |
| Mar2021 | ₹4.03 Cr |
How is Contingent Liabilities of ALBERT DAVID Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹4.62 Cr | 2.17 | |
| Mar2024 | ₹4.52 Cr | 130.38 | |
| Mar2023 | ₹1.96 Cr | 20.22 | |
| Mar2022 | ₹1.63 Cr | -59.46 | |
| Mar2021 | ₹4.03 Cr | - | |
Compare Contingent Liabilities of peers of ALBERT DAVID
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALBERT DAVID | ₹410.0 Cr | 2.7% | -0.6% | -12.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,036.0 Cr | 0.8% | -4.2% | 7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,218.0 Cr | 1.1% | -0.7% | -1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,099.0 Cr | 0% | 1.3% | 40.1% | Stock Analytics | |
| CIPLA | ₹110,897.0 Cr | -0.3% | -4.1% | -8.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,591.0 Cr | 0.4% | -4.5% | -5.2% | Stock Analytics | |
ALBERT DAVID Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALBERT DAVID | 2.7% |
-0.6% |
-12.6% |
| SENSEX | 3.9% |
1.9% |
-6.8% |
You may also like the below Video Courses